Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Moderna, Inc. (MRNA)
Sector: Healthcare; Industry: Biotechnology

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-15 Andres Juan nan Sell 5,000 $137.00 $685,000 Yes
2021-03-12 Bancel Stephane Chief Executive Officer Sell 11,046 $135.73 $1,499,289 No
2021-03-11 Bancel Stephane Chief Executive Officer Sell 19,000 $133.27 $2,532,060 No
2021-03-11 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $133.29 $879,714 Yes
2021-03-10 Andres Juan nan Sell 5,000 $133.24 $666,200 Yes
2021-03-09 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $127.11 $838,926 Yes
2021-03-08 Andres Juan nan Sell 5,000 $129.41 $647,050 Yes
2021-03-08 Zaks Tal Zvi Chief Medical Officer Sell 16,478 $128.59 $2,118,863 Yes
2021-03-05 Bancel Stephane Chief Executive Officer Sell 11,046 $128.18 $1,415,858 No
2021-03-04 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $128.58 $848,628 Yes
2021-03-04 Bancel Stephane Chief Executive Officer Sell 19,000 $136.64 $2,596,200 No
2021-03-03 Hoge Stephen President Sell 20,000 $149.69 $2,993,700 Yes
2021-03-03 Andres Juan nan Sell 5,000 $145.60 $728,000 Yes
2021-03-02 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $153.77 $1,014,882 Yes
2021-03-01 Zaks Tal Zvi Chief Medical Officer Sell 10,000 $150.45 $1,504,518 Yes
2021-03-01 Andres Juan nan Sell 5,000 $153.84 $769,200 Yes
2021-02-26 Bancel Stephane Chief Executive Officer Sell 11,046 $154.70 $1,708,845 No
2021-02-25 Bancel Stephane Chief Executive Officer Sell 19,000 $150.66 $2,862,590 No
2021-02-24 Hoge Stephen President Sell 20,000 $147.92 $2,958,323 Yes
2021-02-24 AFEYAN NOUBAR Director Sell 1,753,697 $146.19 $256,378,924 No
2021-02-23 AFEYAN NOUBAR Director Sell 4,784,404 $152.59 $730,069,590 No
2021-02-22 Andres Juan nan Sell 5,000 $166.63 $833,150 Yes
2021-02-22 Zaks Tal Zvi Chief Medical Officer Sell 5,000 $164.84 $824,196 Yes
2021-02-19 Bancel Stephane Chief Executive Officer Sell 11,046 $174.80 $1,930,893 No
2021-02-18 Bancel Stephane Chief Executive Officer Sell 19,000 $172.97 $3,286,520 No
2021-02-16 Hoge Stephen President Sell 15,000 $182.80 $2,742,000 Yes
2021-02-16 Andres Juan nan Sell 5,000 $182.80 $914,000 Yes
2021-02-12 Hoge Stephen President Sell 5,000 $185.00 $925,000 No
2021-02-12 Bancel Stephane Chief Executive Officer Sell 11,046 $181.98 $2,010,106 No
2021-02-11 Bancel Stephane Chief Executive Officer Sell 10,000 $178.29 $1,782,900 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.